Related Blog Posts
Pharma, Conflicts Of Interest And Fingerpointers
23 hours ago ago from Pharmalot
The controversy over conflicts of interest is taking a twist as a former Merck executive and a medical journal are teaming up to lash out at doctors who have criticized drugmaker behavior in published studies, and have also served as expert witnesses in product-liability litigation. To wit, Laurence Hirsch, a former vice president of medical communications at Merck, published a lengthy essay in a recent issue of Mayo Clinical Proceedings ...
Related contentSecond District Upholds Denial of Certification in In Re Vioxx Class Cases
23 hours ago ago from Bailey Class Action Daily
On December 15, 2009, the Second District (Division 3) upheld the trial court's denial of class certification in In Re Vioxx Class Cases , __ Cal.App. 4th __ (2009). In that case, the plaintiffs sought recovery, on behalf of all persons and entities in California who paid for Vioxx, of the difference in price between what they paid for Vioxx and what they would have paid for a safer, equally effective, pain reliever. The plaintiff’s theory ...
Related contentBreaking News: Denial of class certification affirmed in Vioxx Class Cases
14 hours ago ago from The Complex Litigator Home
With the holidays upon us, the topical and interesting news stories have been few and far between. But the drought cannot last forever. Today, the Court of Appeal (Second Appellate District, Division Three) issued an Opinion in which it affirmed the trial court's denial of class certification in the matter of In re Vioxx Class Cases (December 15, 2009). I will need to read this Opinion with some deliberation before writing an extended post ...
Related contentRelated News
Nothing to see... move along.
Related Videos
Nothing to see... move along.
